CAMP4 Hauls in $30M to Map New Ground with Drug Discovery Tech | Frank Vinluan | 05/31/18 | Boston |
2016’s Last Boston Tech Watch: Akamai, Neurable, Facebook, GM & More | Jeff Bauter Engel | 12/30/16 | Boston |
Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs | Ben Fidler | 02/02/16 | Boston |
Spero Therapeutics Receives $30,000,000 New Funding | VentureDeal | 02/02/16 | Boston |
With Tensha Purchase, Roche Interest in Bradner Startups Continues | David Holley | 01/11/16 | Boston |
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More | Ben Fidler | 01/08/16 | Boston |
C4 Therapeutics Lands $73,000,000 Series A Round | VentureDeal | 01/08/16 | Boston |
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup | Ben Fidler | 01/07/16 | Boston |
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials | Ben Fidler | 01/04/16 | Boston |
Scholar Rock Lands $36,000,000 Series B Financing Round | VentureDeal | 01/04/16 | Boston |
MassChallenge Chooses Jerusalem For Next Startup Accelerator Outpost | Jeff Bauter Engel | 10/28/15 | Boston |
Skillz Lands $15,000,000 Series B Funding | VentureDeal | 09/24/15 | San Francisco |
DraftKings CEO: Early interest From MLB, Kraft Group ‘Eye-Opening’ | David Holley | 07/28/15 | Boston |
DraftKings Garners $300,000,000 Series D Funding Round | VentureDeal | 07/27/15 | Boston |
Delphix Secures $75,000,000 New Round | VentureDeal | 07/13/15 | San Francisco |
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
With $30M, Spero Broadens Fight Against Drug-Resistant Bugs | Ben Fidler | 06/08/15 | Boston |
SynapDx Obtains New Financing | VentureDeal | 03/27/13 | Boston |
Novophage Nets $5.7M from Flybridge, Others | Gregory T. Huang | 05/31/11 | Boston |
Novophage Garners $5,750,000 Series A Funding Round | VentureDeal | 05/31/11 | Boston |
Genzyme Sheds Diagnostics Unit, Novell Acquired by Attachmate, Archemix Sells Hemophilia IP to Baxter, & More Boston-Area Deals News | Erin Kutz | 11/24/10 | Boston |
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner | Ryan McBride | 08/07/09 | Boston |